ToxSci Advance Access originally published online on February 8, 2007
Toxicological Sciences 2007 97(1):75-80; doi:10.1093/toxsci/kfm015
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effect of Manganese on Luteinizing HormoneReleasing Hormone Secretion in Adult Male Rats

* Facultad de Medicina, Centro de Estudios Farmacológicos y Botánicos, CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina
Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas
1 To whom correspondence should be addressed at Facultad de Medicina, Centro de Estudios Farmacológicos y Botánicos, CONICET, Universidad de Buenos Aires, Paraguay 2155, piso 16, CP 1121, Buenos Aires, Argentina. Fax: +54 11 4508 3680. E-mail: jprestifilippo{at}yahoo.com.ar.
Received December 5, 2006; accepted February 5, 2007
| ABSTRACT |
|---|
|
|
|---|
Recently studies have demonstrated that low doses of (Mn+2) in the form of manganese chloride can stimulate specific puberty-related hormones and advance signs of pubertal development in immature female and male rats. In the present study, we used an in vitro system to evaluate the ability of 0, 50, 250, and 500µM doses of Mn+2 to stimulate luteinizing hormonereleasing hormone (LHRH) secretion and to assess the hypothalamic mechanism of this action in adult male Sprague-Dawley rats. We demonstrated that Mn+2 at 500µM, but not the lower doses, increased LHRH release, nitric oxide (NO) synthase (NOS) activity, and the content of cyclic cGMP in the medial basal hypothalamus. Inhibition of NOS with a competitive inhibitor (N
-nitro-L-arginine methyl ester hydrochloride) prevented the Mn-induced increase in LHRH release. Additionally, methylene blue and KT5823, specific inhibitors of guanylyl cyclase and protein kinase G (PKG), respectively, also blocked the stimulatory effect of Mn+2 on LHRH release. These in vitro studies demonstrated that the hypothalamic mechanism of Mn+2 action in adult males is by activation of the NOS/NO system, resulting in increases in cGMP and PKG and thus the secretion of LHRH from the nerve terminals. These results indicate Mn+2 can cause LHRH release in adult males, and this action is discussed in relation to age, gender, as well as mechanistic and functional differences between adult and immature animals. Key Words: nitric oxide; cGMP; protein kinase G; medial basal hypothalamus.
| INTRODUCTION |
|---|
|
|
|---|
Manganese (Mn+2) is an essential trace metal that is involved in the metabolism of carbohydrates, lipids, and proteins and has an important function as a cofactor for a number of enzymes (Keen, 1984
There have been no studies conducted to determine whether Mn+2 can stimulate LHRH release in adult animals. Therefore, this study was conducted to assess the ability of Mn+2 to stimulate LHRH secretion in adult male rats and to discern whether the sensitivity of the stimulation and mechanism of this action at the hypothalamic level differs from immature rats of both sexes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Chemicals.
LHRH for iodination and standards were purchased from Peninsula Laboratories, Inc., Division of Bachem (San Carlos, CA). cGMP for iodinations and standards were purchased from SigmaAldrich (St Louis, MO). 125Iodine for iodination was purchased from New England Nuclear Life Science Product (Boston, MA). Manganese chloride (MnCl2) was purchased from Anedra (San Fernando, Buenos Aires, Argentina). Hepes, DL-dithiothreitol (DTT), reduced nicotinamide adenine dinucleotide phosphate (NADPH), N
-nitro-L-arginine methyl ester hydrochloride (L-NAME), hemoglobin (Hb), and methylene blue (MB) were purchased from SigmaAldrich. Dowex AG 50 W-X8 200400 mesh sodium form was obtained from Bio-Rad (Hercules, CA), and the 14C-arginine monohydrochloride 360 mCi/mmol was from Amersham Pharmacia (Buckinghamshire, UK). The protein kinase G (PKG) inhibitor, KT5823, was purchased from Alomone Lab (Jerusalem, Israel).
Animals.
Male rats of the Sprague-Dawley strain (220250 g) were kept in group cages in an animal room having a photoperiod of 14 h of light (0500 h1900 h) and a room temperature of 22°C24°C. Animals had free access to laboratory chow and tap water. The experimental procedures reported here were approved by the Animal Care Committee of the Center of Experimental Pharmacology and Botanicals of the National Council for Research of Argentina and carried out in accordance with the Declaration of Helsinki.
In vitro incubations.
After decapitation and removal of the brain, the medial basal hypothalamus (MBH) was dissected by making frontal cuts just behind the optic chiasm, extending dorsally 1.0 mm, and a horizontal cut extended from this point caudally to just behind the pituitary stalk, where another frontal cut was made. Longitudinal cuts were made 1.0 mm lateral to the midline bilaterally. The hypothalami (78 for each group) were preincubated individually in glass tubes with 500 µl of Krebs-Ringer bicarbonate-buffered medium (NaH2PO4 1.18mM, NaCl 118.46mM, KCl 5mM, MgCl2 1.18mM, NaHCO3 24.88mM, and CaCl2 2.5mM, containing 0.1% glucose, pH 7.4) alone or with vehicle of the inhibitory drugs for control or with the inhibitory drugs such as, L-NAME, Hb, MB, and KT5823. After this preincubation (15 min), the medium was discarded and replaced with fresh medium alone or with the medium containing the substances to be tested, and the incubation continued for 30 min. The incubation was continuing for 30 min followed by removal of the medium and storage of the samples at 20°C until the respective assays were conducted. All incubations were carried out in a Dubnoff shaker (50 cycles per min; 95% O2/5% CO2) at 37°C.
Radioimmunoassays.
LHRH in the incubation media was measured by radioimmunoassays (RIA) utilizing a highly specific LHRH antiserum kindly provided by Ayela Barnea (University of Texas Southwestern Medical Center, Dallas, TX). The sensitivity of the assay was 0.2 pg per tube, and the curve was linear up to 100 pg of LHRH. The intra-assay coefficient of variation of the LHRH RIA ranged from 7.3%, and the interassay coefficient of variation was 8.9%. All samples were measured in duplicate.
cGMP content was measured by RIA using a highly specific antiserum purchased from SigmaAldrich. The sensitivity of the assay was 0.24 pmol/ml per tube, and the curve was linear up to 25 pmol/ml of cGMP. Intra- and interassay coefficients of variation were 5.0% and 7.0%, respectively.
Determination of NO synthase activity.
Determination of nitric oxide synthase (NOS) activity was performed by a modification (Canteros et al., 1995
) of the 14C-citrulline method of Bredt and Snyder (Bredt and Snyder, 1989
). After the incubation period, the MBHs were immediately homogenized in ice cold 0.5 ml of 20mM Hepes (pH 7.4) with addition of 1.25mM CaCl2 and 1mM DTT. The reaction was started by adding 120µM NADPH and 200,000 dpm of 14C-arginine (360 mCi/mmol) to the homogenates. The tubes were incubated for 15 min at 37°C in a Dubnoff metabolic shaker (50 cycles per min and 95%O2/5%CO2 atmosphere). At the end of this incubation period, the tubes were immediately centrifuged at 10,000 x g for 10 min at 4°C. The supernatants were immediately applied to individual columns containing 1 ml of Dowex AG 50 W-X8 200 mesh sodium form and washed with 2.0 ml of double distilled water. All collected fluid from each column was counted for 14C-citrulline activity in a scintillation counter. Since NOS converts arginine into equimolar quantities of citrulline and NO, the data were expressed as pmol of NO produced per MBH per min.
Statistics.
All data are expressed as the mean (±SEM). Comparisons between groups were performed by using a one-way ANOVA followed by the Student-Newman-Keuls multiple comparison test for unequal replicates. Student's t test was used when comparing two groups. Results were confirmed by at least two independent experiments. Differences with p values <0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
Effect of Mn+2 on the Basal Release of LHRH, NOS Activity, and the Content of cGMP from MBH
Figure 1 shows that the 50 and 250µM doses of the metal did not increase the amount of basal LHRH released from MBH, compared to control group; however, the 500µM dose of Mn+2 was highly effective in inducing (p < 0.001) the release of the peptide. To determine if NO participates in this increased secretion of LHRH produced with the 500µM dose, we measured NOS activity. Results shown in Figure 2 demonstrate that the NOS activity, as assessed by the method of conversion of 14C-arginine into 14C-citrulline, was increased (p < 0.01) by Mn+2 compared to the control group. Furthermore, Figure 3 shows that the content of the nucleotide cGMP, a product of guanylyl cyclase (GC) activity, was concomitantly increased (p < 0.01) as a result of exposure to the Mn+2, an effect that was not observed in the control tissues.
|
|
|
Effect of NOS Inhibition on Mn-Induced cGMP Content and LHRH Release
We demonstrated that Mn+2 (500µM) increased the content of cGMP (Fig. 4a; p < 0.05) and LHRH release (Fig. 4b; p < 0.01) from MBH. L-NAME (1mM), an inhibitor of NOS activity, blocked both of these stimulations induced by the Mn2+. L-NAME alone had no effect on the content of cGMP and LHRH release.
|
Effect of a Scavenger of NO on Mn-Induced LHRH Release
Figure 5 shows that the effect of Mn+2 (500µM) to stimulate (p < 0.01) LHRH release was blocked by the presence of Hb (40 µg/ml), scavenger of NO, in the media. Hb alone had no effect on the basal release of the peptide.
|
Effect of GC Inhibition on Mn-Induced cGMP Content and LHRH Release
Figure 6 shows as before that Mn+2 (500µM) increased both cGMP content (Fig. 6a; p < 0.01) and LHRH release (Fig. 6b; p < 0.01) into the media. This figure also shows that MB (10mM), an inhibitor of GC activity, blocked these stimulatory effects induced by the Mn2+. MB alone had no effect on the content of cGMP and LHRH basal release.
|
Effect of PKG Inhibition on Mn-Induced LHRH Release
Our results demonstrated that the ability of Mn+2 (500µM) to stimulate (p < 0.001) LHRH release was blocked by the presence of KT5823 (1µM), a specific inhibitor of PKG. The KT5823 alone had no effect on the basal LHRH release (Fig. 7).
|
| DISCUSSION |
|---|
|
|
|---|
The present results show that while Mn+2 at doses of 50µM and 250µM did not stimulate LHRH secretion from the basal hypothalamus of adult male Sprague-Dawley rats, the 500µM dose was effective in increasing this secretion. This action to increase LHRH release was due to the ability of Mn+2 to stimulate NOS activity, resulting in increased production of NO and, hence, increased cGMP, PKG, and ultimately, increased LHRH release. These results are the first to demonstrate the effects of Mn+2 on LHRH release in adult animals; however, this stimulatory action of the metal on LHRH release in immature rats of both sexes has been reported previously (Lee et al., 2006
Mn+2 was shown to stimulate LHRH secretion from the basal hypothalamus in immature female rats at a dose of 50µM (Pine et al., 2005
), whereas the dose required to stimulate release of the peptide in immature males was 250µM (Lee et al., 2006
). As shown in the present study, a 500µM dose was needed for LHRH stimulation in the adult males. While the adult males do appear in this regard to be less sensitive than immature males and females, it should be noted that there were modest differences in methodologies between laboratories. The present study used a shorter preincubation period that could have resulted in a greater in vitro basal secretion. Also, the size of the MBH in adult males is larger than those of immature animals and penetration of the metal could have been somewhat less. Taking into account these considerations, the combined results of the studies to date still suggest the potential for both a sex and age difference in sensitivity to Mn+2 with regard to stimulation of LHRH secretion. In that regard, the immature females were 5 and 10 times more sensitive to the metal than immature and mature males, respectively. The immature males were two times more sensitive than the mature males. These hormonal comparisons are the first and lend important support to other reports showing age and gender differences with regard to Mn+2 exposure (Flechter, 1999; Mena, 1974
). Importantly, it has been suggested that infants and children are more sensitive to this substance than adults (Greger, 1999
). Also, gender differences have been observed with male rats clearing the metal two times faster than female rats (Zheng et al., 2000
).
The fact that there is a NO involvement in the Mn+2-stimulated release of LHRH is not surprising since NOS is present in the MBH in juxtaposition to LHRH terminals and has been shown to regulate cGMP and LHRH in adult male and female rats (Bhat et al., 1996
; Rettori et al., 1993
). The Mn+2 dose at which this occurs, however, points to differences that can be drawn between results noted previously in immature females (Lee et al., 2007
). In this regard, we showed in the females that Mn+2 stimulated release of LHRH with a dose as low as 50µM and that this action was not altered by the presence of a NOS inhibitor. Importantly, in the immature females, we showed that low doses of Mn+2 acted downstream to NOS/NO by activating GC directly (Lee et al., 2007
). While Mn+2 can stimulate LHRH release at a lower dose in immature males compared to adult males, studies have not been conducted to discern whether NO plays a role in the immature males. Regardless of this particular mechanism, the gender difference is striking and notable, since a markedly lower dose of Mn+2 will induce LHRH release in immature females compared to either immature or adult males.
Mn+2 is a natural element readily available to the hypothalamus, thus further demonstrating the potential for the Mn+2 influence on LHRH secretion. This metal is able to enter the brain through the cerebral vasculature and the spinal fluid. The mechanism by which Mn+2 crosses the blood-brain barrier is not yet well understood, but involves binding of the metal to transport systems such as transferrin (Aschner and Aschner, 1990
, 2000
). Also, as Mn+2 levels rise in blood, the influx into the spinal fluid rises and entry across the choroid plexus becomes more important (Murphy et al., 1991
). Importantly, Mn+2 accumulates in the hypothalamus (Deskin et al., 1980
; Pine et al., 2005
) and is known to be taken up by both neurons and glial cells (Tholey et al., 1990
) and, hence, suggesting a potential role in neuronal/glial communications within the developing hypothalamus.
The effect of Mn+2 to stimulate LHRH with regard to dose and gender is important and worthy of additional discussion with regard to potential reproductive functions. The fact that immature animals appear more sensitive to the stimulatory effects of Mn+2 on LHRH release than adult animals suggests that the principal facilitative action on reproduction is perhaps most important leading up to and during pubertal maturation. Several lines of evidence support this. Because of the dose of Mn+2 required in the present study to induce LHRH release, adult males exhibit a higher level of resistance to the stimulatory effect of Mn+2. It should be pointed out that it is possible that long-term exposure to the Mn+2 in males could be detrimental and they require higher concentrations of the metal, since an Mn+2 deficiency causes impaired growth and reproduction in both sexes (Boyer et al., 1942
; Smith et al., 1944
), suggesting that there is a role for this metal in reproductive processes. In contrast, the lower dose effect of Mn+2 to stimulate LHRH secretion in immature animals (Lee et al., 2006
; Pine et al., 2005
), especially in females, may be important with regard to normal pubertal development. Interestingly, however, should Mn+2 exposure occur too early in life, this apparent facilitatory or beneficial effect of Mn+2 could be harmful, since it can stimulate LHRH release and contribute to precocious pubertal development in both females and males, with females being twice as sensitive as males (Lee et al., 2006
; Pine et al., 2005
). Importantly, central precocious puberty is a much greater problem in girls with over 65% being idiopathic, compared to less than 10% in boys.
Thus, although modest differences in incubation techniques have been used between laboratories, overall the results suggest there may be dose, age, and gender differences to Mn2+ with immature females being more sensitive than immature males and immature males being more sensitive than adult males. In summary, our results are the first to show that Mn+2 is capable of inducing LHRH secretion in adult male rats. Using an in vitro system, we have discerned that the mechanism of this action is through activation of the hypothalamic NOS/NO system, hence, resulting in stimulation of the cGMP/PKG/LHRH-releasing pathway. Overall, these results suggest that while Mn+2 may facilitate LHRH secretion in adult animals, there are important age and gender differences regarding sensitivity to Mn+2 compared to immature animals of both sexes.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Consejo Nacional de Investigaciones Científicas y Técnicas (Grant CONICET PIP 6149), Agencia Nacional de Promoción Científica y Tecnológica (Grant BID 1201 OC-AR, PICT 03/14264), and the National Institutes of Health (ES013143 and ES09106).
| REFERENCES |
|---|
|
|
|---|
Aschner M, Aschner JL. Manganese transport across the blood brain barrier: Relationship to ion homeostasis. Brain Res. Bull. (1990) 24:857860.[CrossRef][ISI][Medline]
Aschner M, Aschner JL. Brain transport and emerging research needs. Environ. Health Perspect. (2000) 108:429432.[CrossRef][ISI][Medline]
Bhat G, Mahesh VR, Aguon K, Brann DW. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology (1996) 64:93102.[ISI][Medline]
Boyer PH, Shaw JH, Phillips PH. Studies on manganese deficiency in the rat. J. Biol. Chem. (1942) 143:417425.
Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA (1989) 86:90309033.
Canteros G, Rettori V, Franchi A, Genaro A, Cebral E, Faletti A, Gimeno M, McCann SM. Ethanol inhibits luteinizing hormone-releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide. Proc. Natl. Acad. Sci. USA (1995) 92:34163420.
Deskin R, Bursain SJ, Edens FW. Neurochemical alterations induced by manganese chloride in neonatal rats. Neurotoxicology (1980) 2:6573.[ISI]
Fechter LD. Distribution of manganese in development. Neurotoxicology. 20:197201.
Greger JL. Nutrition vs toxicology of manganese in humans: Evaluation of potential biomarkers. Neurotoxicology (1999) 20:205212.[ISI][Medline]
Grey LE, Laskey JW. Multivariate análisis of the effects of manganese on the reproductive physiology and behavior of the male house mouse. J. Toxicol. Environ. Health (1980) 6:861867.[ISI][Medline]
Keen CL, Lonnerdal B, Hurley LS. Manganese. In: Biochemistry of the essential ultratrace elementsFrieden E, ed. (1984) New York: Plenum Press. 89132.
Laskey JW, Rehnberg JF, Hein JF. Effects of chronic manganese exposure on selected reproductive parameters. J. Toxicol. Environ. Health (1982) 9:677687.[ISI][Medline]
Lee B, Hiney JK, Pine MD, Srivastava VK, Dees WL. Manganese stimulates LHRH secretion in prepubertal female rats: Hypothalamic site and mechanism of action. J. Physiol. (2007) 578:765772.
Lee B, Pine M, Johnson L, Rettori V, Hiney JK, Dees WL. Manganese acts centrally to activate reproductive hormone secretion and pubertal development in male rats. Reprod. Toxicol. (2006) 22:580585.[CrossRef][ISI][Medline]
Mena I. The role of manganese in human disease. Ann. Clin. Lab. Sci. (1974) 4:487491.[ISI][Medline]
Murphy VA, Wadhawami KC, Smith OR, Rapoport SI. Saturable transport of manganese across the rat blood brain barrier. J. Neurochem. (1991) 57:948954.[ISI][Medline]
Pine M, Lee B, Dearth R, Hiney JK, Dees WL. Manganese acts centrally to stimulate luteinizing hormone secretion: A potential influence on female pubertal development. Toxicol. Sci. (2005) 85:880885.
Rettori V, Belova N, Dees WL, Nyberg CL, Gimeno M, McCann SM. Role of nitric oxide in the control of luteinizing hormone releasing hormone release in vivo and in vitro. Proc. Natl. Acad. Sci. USA (1993) 90:1013010134.
Smith SE, Medlicott M, Ellis GH. Manganese deficiency in the rabbit. Arch. Biochem. Biophys. (1944) 4:281289.
Tholey G, Megias-Megias L, Wedler FC, Ledig M. Modulation of Mn accumulation in cultured rat neuronal and astroglial cells. Neurochem. Res. (1990) 15:751754.[CrossRef][ISI][Medline]
Zheng W, Kim H, Zhao Q. Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dawley rats. Toxicol. Sci. (2000) 54:295301.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






